There were 233 press releases posted in the last 24 hours and 149,844 in the last 365 days.

Revolutionary Drug-Free Joint, Back Pain Relief Devices By Neuromodulation Technology Award Winner At CES® Eureka Park®

Industry Technology Leader for Noninvasive Pain Relief combines Cool-Pulse tech with novel heat & patented vibration frequencies for low back & shoulder pain.

FLEX and DuoTherm are completely new approaches to pain relief based on ten years of scientific research. We want to change the way people treat and even think about pain.”
— Amy Baxter MD, CEO & Chief Medical Officer, Pain Care Labs

ATLANTA, GEORGIA, US, December 21, 2018 /EINPresswire.com/ -- Pain Care Labs, industry technology leader in noninvasive pain management, announces it will exhibit two new revolutionary pain relief devices at CES® 2019 in Eureka Park® Booth 51723. Combining proven neuromodulatory frequencies with patented and patent-pending hot and cold pain reducers, new VibraCool® Flex and DuoTherm™ Vibrating Back Pain relieve pain on contact.

Priced at $69.95 and $199.95, respectively, Flex (available now) and DuoTherm (available Q4 2019) are reusable hot and cold wearable devices with patented high-frequency oscillatory vibration combinations.

Founded in 2006 by physician-scientist Amy Baxter, Pain Care Labs created Cool-Pulse™ technology to block needle pain. Dr. Baxter initially presented the NIH-researched device on Shark Tank; then expanded the line to include VibraCool for post-operative pain and rehabilitation. This year, the company accepted the Frost & Sullivan award for “Technology Leader in Noninvasive Pain Relief” for expansion of the technology to address pain and the opioid crisis.

Over 28 clinical trials have demonstrated pain relief with the patented technology, more independent science than any other new device at CES. “Neuromodulation devices have used TENS to shock the skin or have required surgical implantation,” explains CEO Dr. Baxter. “We have proven that with specific frequencies, wearable devices can employ neuromodulation more comfortably while leveraging heat, cold, and vibration. These modalities are independently proven to heal tissues faster.”

At CES, the company introduces new devices on the proven, patented Cool-Pulse oscillatory platform. To date, the FDA 510K cleared pain device has blocked pain from over 31 million needle procedures. Building on recent research, the company's new multi-modal VibraCool FLEX treats neck, shoulders, hips, lower back, piriformis, and plantar fasciitis. FLEX is the first device from the company to offer the choice of either heat or cold on its patented neuromodulation platform, offering a multi-modal, drug-free alternative for pain relief and recovery. While at CES, the company will also preview New DuoTherm Vibrating Back Pain reliever, adding additional myofascial trigger point therapy, available Q4 2019.

“Oscillatory frequencies stimulate the neuromodulatory nerves directly, so those frequencies are more effective and more comfortable than shocking the nerves with TENS," observes Dr. Baxter. "We have spent over a decade researching and developing reusable wearable approaches to relieve pain and the nature of pain itself. Chronic pain affects over 100 million people. We are changing the way people treat and even think about pain.”

To schedule a pre-CES press meeting with Pain Care Labs or Dr. Baxter, contact Jennifer Tipping (877) 805 2899 x 707 (US), jtipping@paincarelabs.com. For international calls and for all calls during the event, please call Jennifer Tipping at +1-912-483-9490.

About Pain Care Labs

Founded in 2006 by pediatric emergency doctor and pain researcher Amy Baxter MD FAAP FACEP, Pain Care Labs is on a mission to eliminate unnecessary pain. Using the physiologic technique of “gate control” and conditioned pain modulation (CPM), the company's devices block pain by stimulating the motion nerves and thermal nerve feedback system. The company's research has clinically determined the frequency that naturally stimulates the motion nerves with comfortable vibration, while intense ice packs reduce inflammation and add inhibitory and CPM pain relief. The company’s award-winning NIH funded first device, Buzzy for Shots, created a new FDA category of pain reliever. In 2017 the company was awarded the “Industry Leader in Local Pain Relief” from Frost & Sullivan. Buzzy is used worldwide and has blocked pain from over 31 million needles. VibraCool is used for athletic, rehabilitation and post-operative pain. See other projects and company information at http://www.paincarelabs.com

Jennifer Tipping
Pain Care Labs
+1 912-483-9490
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

VibraCool Video - Simple Serious Relief


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.